Back to News
Market Impact: 0.2
Butterfly Network Lands Multi-Year Bridge Neurotech Deal
Source: benzinga.com
Technology & InnovationHealthcare & Biotech
Butterfly Network (NYSE: BFLY) is partnering with Bridge Neurotech to develop a fully non-invasive brain-computer interface using ultrasound technology. The article gives no development timeline, financial terms, or evidence of a commercial launch.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
BFLY0.70
More News
- Elon Musk blames Indian 'oligarchs' for stalling Starlink launch
- FCC to vote on auctioning 25MHz of 'prime spectrum' in move that could benefit Amazon, SpaceX
- Microsoft shows off new Windows software, revamped for agentic AI
- Wolfspeed secures $1.5 billion conditional loan commitment from US defense department
- Microsoft to sell $2,599 Surface Laptop Ultra containing Nvidia AI chip
- New data strengthens our faith in a TJX comeback. Plus, the Nvidia-Microsoft PC is here
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Index and ETF Holdings Data for AI Research
- Capital Intensity as Gravity: The AI Trade Enters Its Industrial Era (Looking at Q3 2025 Earnings in Tech)